Related references
Note: Only part of the references are listed.LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A
Qi Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Differential expression of matrix metalloproteinases and miRNAs in the metastasis of oral squamous cell carcinoma
Zhen-Hu Ren et al.
BMC ORAL HEALTH (2020)
FOXM1 functions collaboratively with PLAU to promote gastric cancer progression
Chao Ai et al.
JOURNAL OF CANCER (2020)
Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis
Ke Yang et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
MicroRNA-193a-3p suppresses the colorectal cancer cell proliferation and progression through downregulating the PLAU expression
Maosong Lin et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Identification of potential hub genes associated with the pathogenesis and prognosis of pancreatic duct adenocarcinoma using bioinformatics meta-analysis of multi-platform datasets
Yufan Ma et al.
ONCOLOGY LETTERS (2019)
Prediction of Flap Compromise by Preoperative Coagulation Parameters in Head and Neck Cancer Patients
Kun Wu et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2018)
Effect of a synthetic inhibitor of urokinase plasminogen activator on the migration and invasion of human cervical cancer cells in vitro
Xuechun Wang et al.
MOLECULAR MEDICINE REPORTS (2018)
uPA/uPAR signaling in rheumatoid arthritis: Shedding light on its mechanism of action
Palani Dinesh et al.
PHARMACOLOGICAL RESEARCH (2018)
High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism
Sophie Vacher et al.
PLOS ONE (2018)
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
Niaz Mahmood et al.
FRONTIERS IN ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Application of weighted gene co-expression network analysis to identify key modules and hub genes in oral squamous cell carcinoma tumorigenesis
Xiaoqi Zhang et al.
ONCOTARGETS AND THERAPY (2018)
Prognostic value of urokinase plasminogen activator system in non-small cell lung cancer: A systematic review and meta-analysis
Jia-Ju Lu et al.
MOLECULAR AND CLINICAL ONCOLOGY (2018)
p120-Catenin Downregulation and PIK3CA Mutations Cooperate to Induce Invasion through MMP1 in HNSCC
Michal Kidacki et al.
MOLECULAR CANCER RESEARCH (2017)
Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors
Concetta Di Mauro et al.
SCIENTIFIC REPORTS (2017)
Transcriptional complexity and roles of Fra-1/AP-1 at the uPA/Plau locus in aggressive breast cancer
Gabriel Moquet-Torcy et al.
NUCLEIC ACIDS RESEARCH (2014)
The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expression
L. Lv et al.
CELL DEATH & DISEASE (2014)
Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients
N. Harbeck et al.
EUROPEAN JOURNAL OF CANCER (2013)
Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1
Manfred Schmitt et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
Head and Neck Cancers
David G. Pfister et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2011)
Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9
M. G. Martinez-Hernandez et al.
REPRODUCTION (2011)
The molecular biology of head and neck cancer
C. Rene Leemans et al.
NATURE REVIEWS CANCER (2011)
Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world
Farin Kamangar et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Share Paper
